NasdaqGS - Delayed Quote USD
Dyne Therapeutics, Inc. (DYN)
14.78
+0.38
+(2.64%)
At close: June 10 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-319,725
-292,369
-188,158
-153,645
-119,563
Investing Cash Flow
-22,781
-204,076
83,311
87,202
-137,892
Financing Cash Flow
542,748
809,895
54,322
37,390
157,821
End Cash Position
474,197
437,391
123,941
174,466
203,519
Interest Paid Supplemental Data
--
--
--
--
0
Capital Expenditure
-3,166
-2,376
-729
-3,067
-3,618
Issuance of Capital Stock
516,232
773,051
52,369
36,861
157,237
Issuance of Debt
--
--
--
--
0
Repayment of Debt
--
--
--
--
0
Free Cash Flow
-322,891
-294,745
-188,887
-156,712
-123,181
12/31/2021 - 9/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNA Avidity Biosciences, Inc.
33.62
+2.94%
EWTX Edgewise Therapeutics, Inc.
15.45
+1.25%
NAMS NewAmsterdam Pharma Company N.V.
21.84
+8.33%
CGEM Cullinan Therapeutics, Inc.
9.03
+3.08%
PCVX Vaxcyte, Inc.
37.20
0.00%
WVE Wave Life Sciences Ltd.
7.23
+2.55%
SION Sionna Therapeutics, Inc.
18.26
+10.94%
AKRO Akero Therapeutics, Inc.
54.52
-0.35%
JANX Janux Therapeutics, Inc.
26.24
+1.16%
CNTA Centessa Pharmaceuticals plc
12.12
+1.51%